Greetings!
November is Epilepsy Awareness Month, a time to bring attention to a widespread yet often misunderstood brain disorder that affects 50 million people worldwide.
At Genomenon, we are committed to supporting epilepsy research and care through innovative genomic solutions.
We’ve published a new blog exploring the genetic foundations of epilepsy, highlighting the crucial role of genomic data in advancing diagnosis and treatment.
As we shared earlier this month, to further support researchers and clinicians, we are offering free access throughout November to curated variant insights for epilepsy-related genes, including ALDH7A1, AP3B2, KCNT1, PLPBP, SCN3A, DEPDC5, SCN8A, ARV1, and DENND5A, available through Mastermind.
Read the latest blog to learn how curated genomic data is making a difference in epilepsy research and care:
The variant content will be accessible to all Mastermind users until the end of November.
Create your free Mastermind account today to access these valuable insights:
CREATE A MASTERMIND ACCOUNT
Let’s work together to drive innovation in epilepsy research and pave the way for better outcomes for patients and their families.
Explore & Discover!
The Genomenon Team
Learn more about Genomenon at genomenon.com and follow them on LinkedIn and Twitter.
